Argeris N. Karabelas
Chief Executive Officer, NITROMED INC.
Companies
- REGENXBIO Inc.Board member Sep 16, 2015 to now1
- Bausch HealthBoard member Jun 21, 2016 to Jun 28, 20222
- Rocket Pharmaceuticals Inc.Board member Feb 17, 2015 to Jun 26, 20153
- Vanda Pharmaceuticals Inc.Board member Feb 22, 2007 to Jun 17, 20114
- Vanda Pharmaceuticals Inc.Chair Apr 12, 2006 to Dec 14, 20065
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bausch Health BHC123,715 shares6$780.0K at $6.30Jun 24, 2022- REGENXBIO Inc. RGNX28,861 shares7$206.8K at $7.17May 29, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 29, 2026Granted 9,807 shares of REGENXBIO Inc.7
- May 30, 2025Granted 7,768 shares of REGENXBIO Inc.8
- Oct 1, 2024Sold 10,000 shares at $10.11 of REGENXBIO Inc.9
- Oct 1, 2024Exercised options 10,000 shares at $3.76 of REGENXBIO Inc.9
- Sep 3, 2024Sold 700 shares at $12.34 of REGENXBIO Inc.10
- Sep 3, 2024Sold 9,300 shares at $11.50 of REGENXBIO Inc.10
- Sep 3, 2024Exercised options 10,000 shares at $3.76 of REGENXBIO Inc.10
- Aug 1, 2024Sold 100 shares at $15.00 of REGENXBIO Inc.11
- Aug 1, 2024Sold 400 shares at $14.59 of REGENXBIO Inc.11
- Aug 1, 2024Sold 9,600 shares at $13.45 of REGENXBIO Inc.11
- Aug 1, 2024Exercised options 100 shares at $12.74 of REGENXBIO Inc.11
- Aug 1, 2024Exercised options 10,000 shares at $3.76 of REGENXBIO Inc.11
- Jul 29, 2024Sold 11,000 shares at $15.05 of REGENXBIO Inc.12
- Jul 29, 2024Exercised options 11,000 shares at $12.74 of REGENXBIO Inc.12
- Jul 1, 2024Sold 10,000 shares at $11.27 of REGENXBIO Inc.13
- Jul 1, 2024Exercised options 10,000 shares at $3.76 of REGENXBIO Inc.13
- May 31, 2024Granted 4,790 shares of REGENXBIO Inc.14
- Jun 2, 2023Granted 3,486 shares of REGENXBIO Inc.15
- Jun 24, 2022Granted 34,387 shares of Bausch Health6
- Jun 3, 2022Granted 3,010 shares of REGENXBIO Inc.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARREGENXBIO Inc., Board member
- 2SEC EDGARBausch Health, Board member
- 3
- 4
- 5SEC EDGARVanda Pharmaceuticals Inc., Chair
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 3, 2025
- 9SEC EDGARForm 4 filed Oct 2, 2024
- 10SEC EDGARForm 4 filed Sep 4, 2024
- 11SEC EDGARForm 4 filed Aug 5, 2024
- 12SEC EDGARForm 4 filed Jul 30, 2024
- 13SEC EDGARForm 4 filed Jul 3, 2024
- 14SEC EDGARForm 4 filed Jun 4, 2024
- 15SEC EDGARForm 4 filed Jun 6, 2023
- 16SEC EDGARForm 4 filed Jun 7, 2022